By Tashi McQueenAFRO Staff [email protected] Type 2 diabetes mellitus (T2DM) is a chronic, life-altering condition affecting more than 35 million Americans. The disease occurs when a person’s ...

The Phase 1b study is designed to evaluate the safety and tolerability of orally administered balomenib over a 28-day treatment period, followed by a post-treatment observation phase of up to ...

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

Medically reviewed by Danielle Weiss, MD Key Takeaways Diabetes can be easily misdiagnosed because its symptoms are similar ...

While uncontrolled diabetes is unfolding as a silent crisis in India, resulting in organ damage and failure, metabolic ...

Jessica Migala has been a health, fitness, and nutrition writer for almost 15 years. She has contributed to more than 40 print and digital publications, including Health and Runner's World. Jessica ...

A recent study found a substantial time-dependent decrease in acute blood glucose levels (FBS and PPBS) in patients with type ...

The prevalence of hearing loss among individuals with type 2 diabetes ranged from 40.6% to 71.9%, significantly higher than ...